These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8701659)
1. [The effect of the conditions for Neisseria meningitidis cultivation on the protein composition in the protein-polysaccharide complex--the base of meningococcal serogroup B vaccine]. Kuvakina VI; Basnak'ian IA; Aleksakhina NN; Artiukhova II; Bobyleva GV; Omarova SM Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):60-3. PubMed ID: 8701659 [TBL] [Abstract][Full Text] [Related]
2. [The effect of the nature of the strain on the character of the production of iron-dependent proteins by meningococci]. Gorbacheva BO; Filatova TN; Petrov AB Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):14-7. PubMed ID: 1811380 [TBL] [Abstract][Full Text] [Related]
3. Development of a second generation group B meningococcal vaccine. Frasch CE; Sacchi CT; Brandiolone MC; Vieiera VS; Leite LC NIPH Ann; 1991 Dec; 14(2):225-30; discussion 230-1. PubMed ID: 1812436 [TBL] [Abstract][Full Text] [Related]
4. [Synthesis of group-specific polysaccharide by different strains of Neisseria meningitidis serogroup B under various conditions]. Sivtseva LD; Levina LA Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):11-5. PubMed ID: 3129885 [TBL] [Abstract][Full Text] [Related]
5. [The molecular parameters of a meningococcal serogroup B protein-polysaccharide vaccine]. Bobyleva GV; Artiukhova II; Kuvakina VI; Basnak'ian IA Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):39-43. PubMed ID: 9082727 [TBL] [Abstract][Full Text] [Related]
6. [The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration]. Basnak'ian IA; Alliluev AP; Kuvakina VI; Aleksakhina NN; Kotel'nikova OV; Chulok TA; Karabak Vi; Borovkova VM; Valerius II; Gofman IL Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):66-7. PubMed ID: 7879546 [No Abstract] [Full Text] [Related]
7. In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis. Ferreirós CM; Ferrón L; Criado MT FEMS Immunol Med Microbiol; 1994 Jan; 8(1):63-8. PubMed ID: 8156052 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Pettersson A; Kuipers B; Pelzer M; Verhagen E; Tiesjema RH; Tommassen J; Poolman JT Infect Immun; 1990 Sep; 58(9):3036-41. PubMed ID: 1696939 [TBL] [Abstract][Full Text] [Related]
9. Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines. Banerjee-Bhatnagar N; Frasch CE Infect Immun; 1990 Sep; 58(9):2875-81. PubMed ID: 2117572 [TBL] [Abstract][Full Text] [Related]
10. [The use of an immunoblotting method for the study of the specificity of the iron-regulated proteins in meningococcus]. Filatova TN; Gorbacheva BO; Vartanian IuP; Efremova VN; Egorova NB; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):68-9. PubMed ID: 7521555 [No Abstract] [Full Text] [Related]
11. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Noronha CP; Struchiner CJ; Halloran ME Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439 [TBL] [Abstract][Full Text] [Related]
12. Status of a group B Neisseria meningitidis vaccine. Frasch CE Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731 [No Abstract] [Full Text] [Related]
13. [The isolation and immunochemical characteristics of the basic iron-regulated protein in meningococci]. Filatova TN; Gamzulina LN Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):24-9. PubMed ID: 9245135 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness of group-A and -C meningococcal polysaccharide vaccines by molecular parameters]. Bobyleva GV; Kuvakina VI; Valerius II Antibiot Med Biotekhnol; 1987 Oct; 32(10):758-63. PubMed ID: 3122649 [TBL] [Abstract][Full Text] [Related]
15. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate. Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the immunological activity and safety of group B meningococcal vaccine prepared from a natural complex of specific polysaccharide and outer membrane proteins]. Kuvakina VI; Golovina LI; Mishina AI; Skirda TA; Bobyleva GV; Mikheeva NG; Chernyshova TF; Temper RM; Ermolenko ZN Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):33-7. PubMed ID: 12043150 [TBL] [Abstract][Full Text] [Related]
17. Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Frasch CE; Peppler MS Infect Immun; 1982 Jul; 37(1):271-80. PubMed ID: 6809629 [TBL] [Abstract][Full Text] [Related]
18. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice. Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856 [TBL] [Abstract][Full Text] [Related]
19. [The biochemical and immunochemical characteristics of the protein preparations obtained by different methods from a biomass of Neisseria meningitidis serogroup B]. Karabak VI; Basnak'ian IA; Aleksakhina NN Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):92-9. PubMed ID: 8059582 [TBL] [Abstract][Full Text] [Related]
20. [The effect of detergents on the immunological activity of the antigens of Neisseria meningitidis serogroup B[]. Bugaev LV; Shkurina EA; Karabak VI; Alliluev AP; Petrov AB Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):11-5. PubMed ID: 8059561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]